Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00526786 · ClinicalTrials.gov registry record · Phase 4
Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus
A Phase 4 study, sponsored by CSA Medical.
- Terminated
- Registry status
- Phase 4
- Development phase
- 78
- Enrollment target
NCT00526786 is a Phase 4 study that was terminated before completion, run by CSA Medical. The registered enrollment target is 78 participants.
The verdict
NCT00526786, a Phase 4 study, was terminated before completion, sponsored by CSA Medical.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 78 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the CryoSpray Ablation System to treat esophageal low grade dysplasia (LGD) or high grade dysplasia (HGD) within Barrett's Esophagus (BE).
Interventions
- DEVICE CryoSpray Ablation System (510(k) NO: K070893)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00526786
The ClinicalTrials.gov registry entry for NCT00526786 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CSA Medical, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CryoSpray Ablation System (510(k) NO: K070893) is the first listed.
NCT00526786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00526786 about?
NCT00526786 is a clinical study titled "Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus". The purpose of this study is to evaluate the safety and effectiveness of the CryoSpray Ablation System to treat esophageal low grade dysplasia (LGD) or high grade dysplasia (HGD) within Barrett's Esophagus (BE).
What is the current status of trial NCT00526786?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2007-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00526786?
The interventions under investigation include: CryoSpray Ablation System (510(k) NO: K070893) (DEVICE).
Who is sponsoring clinical trial NCT00526786?
This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.